MEDICAL PROPERTIES TRUST INC - Common Stock, $0.001 par value per share (MPW)

Historical Holders from Q1 2014 to Q1 2025

Symbol
MPW on NYSE
CUSIP
58463J304
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
600M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
364M
Holdings value
$1.44B
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
468
Number of buys
162
Number of sells
-281
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MEDICAL PROPERTIES TRUST INC - Common Stock, $0.001 par value per share (MPW)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Yet Daniel 8.69% 0% $315M 52.2M 0% Yet Daniel Dec 31, 2024
He Zhengxu 7.1% $256M 42.5M He Zhengxu Dec 31, 2024

Institutional Holders of MEDICAL PROPERTIES TRUST INC - Common Stock, $0.001 par value per share (MPW)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 10M $60.5M -$2.92M $6.03 68
2024 Q4 364M $1.44B -$84.4M $3.95 468
2024 Q3 381M $2.23B -$5.13M $5.85 505
2024 Q2 384M $1.66B -$188M $4.31 503
2024 Q1 425M $1.99B -$30.6M $4.70 511
2023 Q4 429M $2.11B -$119M $4.91 526
2023 Q3 448M $2.44B -$76.2M $5.45 525
2023 Q2 457M $4.24B +$89.2M $9.26 584
2023 Q1 436M $3.59B -$218M $8.22 605
2022 Q4 462M $5.15B -$29.8M $11.14 618
2022 Q3 477M $5.67B -$27.5M $11.86 567
2022 Q2 476M $7.29B +$17M $15.27 572
2022 Q1 477M $10.1B -$177M $21.14 582
2021 Q4 480M $11.3B +$74.2M $23.63 610
2021 Q3 484M $9.73B +$190M $20.07 547
2021 Q2 474M $9.53B -$60.1M $20.10 544
2021 Q1 477M $10.1B +$767M $21.28 537
2020 Q4 439M $9.58B +$154M $21.79 522
2020 Q3 432M $7.62B -$272M $17.63 499
2020 Q2 437M $8.22B +$163M $18.80 479
2020 Q1 437M $7.56B +$46.6M $17.29 479
2019 Q4 434M $9.16B +$1.33B $21.11 499
2019 Q3 371M $7.26B +$1.04B $19.56 440
2019 Q2 319M $5.57B +$90.3M $17.44 428
2019 Q1 319M $5.9B +$523M $18.51 457
2018 Q4 291M $4.69B +$140M $16.08 413
2018 Q3 282M $4.21B -$16.5M $14.91 365
2018 Q2 285M $4B -$19.2M $14.04 360
2018 Q1 290M $3.76B -$77M $13.00 366
2017 Q4 295M $4.06B -$62.7M $13.78 357
2017 Q3 299M $3.93B -$109M $13.13 328
2017 Q2 305M $3.92B +$336M $12.87 338
2017 Q1 288M $3.72B +$428M $12.89 317
2016 Q4 292M $3.6B +$338M $12.30 329
2016 Q3 264M $3.89B +$937M $14.77 336
2016 Q2 200M $3.05B +$79.8M $15.21 307
2016 Q1 195M $2.53B +$79M $12.98 281
2015 Q4 189M $2.17B -$61.3M $11.51 291
2015 Q3 194M $2.15B +$255M $11.06 278
2015 Q2 164M $2.15B +$15.9M $13.11 275
2015 Q1 168M $2.48B +$438M $14.74 268
2014 Q4 138M $1.9B +$87M $13.78 250
2014 Q3 132M $1.62B +$24M $12.26 245
2014 Q2 130M $1.72B -$62.9M $13.24 232
2014 Q1 132M $1.69B +$115M $12.79 243